DRMA logo

Dermata Therapeutics, Inc. (DRMA)

Profile

Full Name

Dermata Therapeutics, Inc.

Ticker

NASDAQ: DRMA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

August 13, 2021

Indexes

Not included

Website

https://www.dermatarx.com

Employees

8

Key Details

Price

$5.74(+7.29%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$80.30(-100.50% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $5.74
    DRMA price is $5.74

    30-Day Relative Volume

    1.03
    DRMA 30-day relative volume is 1.03

    Price Performance

    Price Most recent change

    +7.29%
    DRMA price was up +7.29% on Aug 29, 2025

    Price YTD change

    -57.48%
    DRMA price is down -57.48% since January 1st

    Price 1-year change

    -66.63%
    DRMA price is down -66.63% year-on-year

    Price 3-year change

    -99.62%
    DRMA price is down -99.62% over the past 3 years

    Price Range

    Price All-time high

    $16.68K
    DRMA price is currently -99.97% below its historical high of $16.68 thousand

    Price 3-year low

    $5.09
    DRMA price is currently +12.77% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $3.91M
    DRMA market capitalization is $3.91 million

    Market cap 3-year change

    -37.9%
    DRMA market capitalization is down -37.9% over the past 3 years

    Market cap All-time high

    $52.50M
    DRMA market capitalization is currently -92.55% below its historical high of $52.50 million

    Market cap sector rank

    8.29%
    DRMA market capitalization is higher than 8.29% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +417.93%
    DRMA shares outstanding is up +417.93% year-on-year

    Shares Outstanding 3-Year Change

    +16128.57%
    DRMA shares outstanding is up +16128.57% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.36
    DRMA beta is 0.36

    200-day SMA

    $9.55
    DRMA price is currently -39.91% below its 200-day simple moving average

    50-day SMA

    $6.39
    DRMA price is currently -10.16% below its 50-day simple moving average

    RSI

    45.48
    DRMA 14-day relative strength index is 45.48

    Volume

    1.03
    DRMA 30-day relative volume is 1.03

    ATR

    $0.53
    DRMA average true range is $0.53

    10-day Historical Volatility

    73.14%
    DRMA 10-day historical volatility is 73.14%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    DRMA annual revenue is $0.00

    Revenue Analysts estimate

    -
    DRMA annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    DRMA annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.64%
    DRMA annual revenue is higher than 28.64% of companies in Healthcare sector

    EPS

    EPS

    -$80.30
    DRMA annual earnings per share is -$80.30

    EPS Analysts estimate

    -$7.76
    DRMA annual earnings per share is currently +934.79% higher than the consensus analysts' forecast

    EPS 1-year change

    -100.5%
    DRMA annual earnings per share is down -100.5% year-on-year

    EPS Sector rank

    3.16%
    DRMA annual earnings per share is higher than 3.16% of companies in Healthcare sector

    Profit

    Gross profit

    $0.00
    DRMA annual gross profit is $0.00

    Gross margin

    -
    DRMA annual gross profit margin value is unknown

    Operating profit

    -$12.51M
    DRMA annual operating income is -$12.51 million

    Operating margin

    -
    DRMA annual operating profit margin value is unknown

    Net income

    -$12.29M
    DRMA annual net profit is -$12.29 million

    Net margin

    -
    DRMA annual net profit margin value is unknown

    Expenses

    Total expenses

    $12.51M
    DRMA annual total expenses is $12.51 million

    Operating expenses

    $12.51M
    DRMA annual total operating expenses is $12.51 million

    Cost of goods sold

    $0.00
    DRMA annual cost of goods sold is $0.00

    Selling, general & administrative expenses

    $4.31M
    DRMA annual SGA is $4.31 million

    Depreciation and amortization

    -
    DRMA annual depreciation & amortization value is unknown

    Interest expense

    $0.00
    DRMA annual interest expense is $0.00

    Income tax

    $0.00
    DRMA annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$12.51M
    DRMA annual earnings before interest & taxes is -$12.51 million

    EBITDA

    -$12.51M
    DRMA annual EBITDA is -$12.51 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $3.53M
    DRMA annual total assets is $3.53 million

    Non current assets

    $0.00
    DRMA annual long term assets is $0.00

    Current assets

    $3.53M
    DRMA annual total current assets is $3.53 million

    Cash and cash equivalents

    $3.16M
    DRMA annual cash & cash equivalents is $3.16 million

    Accounts receivable

    -
    DRMA annual accounts receivable value is unknown

    Inventory

    $0.00
    DRMA annual inventory is $0.00

    Liabilities

    Total liabilities

    $1.97M
    DRMA annual total liabilities is $1.97 million

    Long term liabilities

    $0.00
    DRMA annual total long term liabilities is $0.00

    Current liabilities

    $1.97M
    DRMA annual total current liabilities is $1.97 million

    Accounts payable

    $808.00K
    DRMA annual accounts payable is $808.00 thousand

    Debt

    Total debt

    $0.00
    DRMA annual total debt is $0.00

    Total debt 1-year change

    0%
    DRMA annual total debt has remained unchanged year-on-year

    Long term debt

    $0.00
    DRMA annual long term debt is $0.00

    Short term debt

    $0.00
    DRMA annual short term debt is $0.00

    Equity & Capital

    Shareholders equity

    $1.56M
    DRMA annual stockholders equity is $1.56 million

    Book value

    $1.56M
    DRMA annual book value is $1.56 million

    Retained earnings

    -$65.68M
    DRMA annual retained earnings is -$65.68 million

    Working capital

    $1.56M
    DRMA annual working capital is $1.56 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$11.16M
    DRMA annual cash flow from operations is -$11.16 million

    Cash from operations 1-year change

    -74.18%
    DRMA annual cash flow from operations is down -74.18% year-on-year

    Cash from investing

    $0.00
    DRMA annual cash flow from investing activities is $0.00

    Cash from investing 1-year change

    0%
    DRMA annual cash flow from investing activities has remained unchanged year-on-year

    Cash from financing

    $6.89M
    DRMA annual cash flow from financing activities is $6.89 million

    Cash from financing 1-year change

    -9.46%
    DRMA annual cash flow from financing activities is down -9.46% year-on-year

    CAPEX

    CAPEX

    $0.00
    DRMA annual capital expenditures is $0.00

    CAPEX 1-year change

    0%
    DRMA annual capital expenditures has remained unchanged year-on-year

    Free Cash Flow

    Free cash flow

    -$11.16M
    DRMA annual free cash flow is -$11.16 million

    Free cash flow 1-year change

    -74.18%
    DRMA annual free cash flow is down -74.18% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    DRMA annual gross profit margin value is unknown

    Operating margin

    -
    DRMA annual operating profit margin value is unknown

    Net margin

    -
    DRMA annual net profit margin value is unknown

    ROA & ROE

    ROA

    -213.46%
    DRMA annual return on assets is -213.46%

    ROE

    -310.44%
    DRMA annual return on equity is -310.44%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    DRMA price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    DRMA price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.70
    DRMA price to book ratio is 0.70

    PB ratio Sector rank

    28.84%
    DRMA price to book ratio is higher than 28.84% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    DRMA price to sales ratio value is unknown

    PS ratio Sector rank

    -
    DRMA price to sales ratio is unknown

    Enterprise value

    Enterprise value

    -$2.57M
    DRMA enterprise value is -$2.57 million

    Enterprise value Sector rank

    8.59%
    DRMA enterprise value is higher than 8.59% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    0.24
    DRMA EV/EBITDA is 0.24

    EV/EBITDA Sector rank

    68.23%
    DRMA EV/EBITDA is higher than 68.23% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.79
    DRMA annual current ratio is 1.79

    Quick ratio

    1.79
    DRMA annual quick ratio is 1.79

    Leverage

    Debt to equity

    0.00
    DRMA annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    DRMA annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    DRMA piotroski f-score value is unknown

    Altman Z-Score

    -35.98
    DRMA altman z-score is -35.98

    Analyst ratings

    Recent major analysts updates

    Aug 21, 25 Maxim Group
    Buy
    May 21, 25 Maxim Group
    Buy
    Aug 21, 24 Maxim Group
    Buy
    Mar 23, 23 Maxim Group
    Buy
    Sep 21, 21 Brookline Capital
    Buy
    Sep 14, 21 Maxim Group
    Buy

    Institutional Ownership

    Screeners with DRMA included

    Growing Shares Outstanding
    US stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotech Companies
    • What is the ticker symbol for Dermata Therapeutics, Inc.?
    • Does Dermata Therapeutics, Inc. pay dividends?
    • What sector is Dermata Therapeutics, Inc. in?
    • What industry is Dermata Therapeutics, Inc. in?
    • What country is Dermata Therapeutics, Inc. based in?
    • When did Dermata Therapeutics, Inc. go public?
    • Is Dermata Therapeutics, Inc. in the S&P 500?
    • Is Dermata Therapeutics, Inc. in the NASDAQ 100?
    • Is Dermata Therapeutics, Inc. in the Dow Jones?
    • When was Dermata Therapeutics, Inc.'s last earnings report?
    • When does Dermata Therapeutics, Inc. report earnings?

    What is the ticker symbol for Dermata Therapeutics, Inc.?

    The ticker symbol for Dermata Therapeutics, Inc. is NASDAQ:DRMA

    Does Dermata Therapeutics, Inc. pay dividends?

    No, Dermata Therapeutics, Inc. does not pay dividends

    What sector is Dermata Therapeutics, Inc. in?

    Dermata Therapeutics, Inc. is in the Healthcare sector

    What industry is Dermata Therapeutics, Inc. in?

    Dermata Therapeutics, Inc. is in the Biotechnology industry

    What country is Dermata Therapeutics, Inc. based in?

    Dermata Therapeutics, Inc. is headquartered in United States

    When did Dermata Therapeutics, Inc. go public?

    Dermata Therapeutics, Inc.'s initial public offering (IPO) was on August 13, 2021

    Is Dermata Therapeutics, Inc. in the S&P 500?

    No, Dermata Therapeutics, Inc. is not included in the S&P 500 index

    Is Dermata Therapeutics, Inc. in the NASDAQ 100?

    No, Dermata Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Dermata Therapeutics, Inc. in the Dow Jones?

    No, Dermata Therapeutics, Inc. is not included in the Dow Jones index

    When was Dermata Therapeutics, Inc.'s last earnings report?

    Dermata Therapeutics, Inc.'s most recent earnings report was on November 15, 2021

    When does Dermata Therapeutics, Inc. report earnings?

    The date for Dermata Therapeutics, Inc.'s next earnings report has not been announced yet
    On this page